Both in Pharmaceuticals
Skye Bioscience vs Imunon
Over the past year SKYE returned −88.3% and IMNN returned −82.0%; their daily moves had a correlation of 0.12.
SKYE −88.3% IMNN −82.0%Growth of $1, one year, split-adjusted
| Metric | SKYE | IMNN |
|---|---|---|
| Price | $1.51 | $0.8512 |
| Market cap | $6.7M | $4.8M |
| Today | +4.14% | −2.85% |
| 1 month | −5.0% | −36.2% |
| 6 months | −78.9% | −68.2% |
| Year to date | −74.8% | −77.7% |
| 1 year | −88.3% | −82.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.9M | -$169.7K |
| Dividend yield | — | — |
| Volatility (60d) | 617.0% | 91.1% |
| Short % of float | 0.6% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).